Stem Cells Spin Spolka Akcyjna Logo

Stem Cells Spin Spolka Akcyjna

SCS | WAR

Overview

Corporate Details

ISIN(s):
PLSTCLS00013 (+2 more)
LEI:
259400ZBL6DOUA86FW60
Country:
Poland
Address:
WROCŁAW KONOPNICKIEJ 15B, 51-141 WROCŁAW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Stem Cells Spin S.A. is a biotechnology company focused on the commercialization of proprietary inventions related to MIC-1 stem cells. The company develops and utilizes innovative, patented methods for the cultivation of these cells and the production of natural biological substances with significant regenerative potential. Its core activities are centered on leveraging its low-cost and effective technology to research and develop novel products for applications in regenerative medicine. The company's foundational technology is based on scientific discoveries originating from the Medical University of Wroclaw.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Stem Cells Spin Spolka Akcyjna. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-30 10:15
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 723 bytes
2025-06-04 19:37
M&A Activity
Zawarcie umowy o zachowaniu poufności (NDA) w celu przeprowadzenia badania due …
Polish 1.3 KB
2025-05-30 13:51
Declaration of Voting Results & Voting Rights Announcements
liczba głosów i akcji w spółce
Polish 684.5 KB
2025-05-30 13:51
Proxy Solicitation & Information Statement
wzór pełnomocnictwa
Polish 2.3 MB
2025-05-30 13:51
Post-Annual General Meeting Information
projekty uchwał
Polish 941.6 KB
2025-05-30 13:51
Pre-Annual General Meeting Information
ogłoszenie o zwołaniu ZWZ
Polish 807.6 KB
2025-05-30 13:51
Pre-Annual General Meeting Information
Zwołanie Zwyczajnego Walnego Zgromadzenia Spółki na 26 czerwca 2025 roku - Cont…
Polish 805 bytes
2024-12-23 20:53
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 726 bytes
2024-11-22 19:34
Regulatory News Service
Otrzymanie przez Marka Cegielskiego - członka Rady Nadzorczej tytułu profesora …
Polish 1.2 KB
2024-11-22 14:22
Declaration of Voting Results & Voting Rights Announcements
informacja i liczbie akcji i głosów
Polish 684.5 KB
2024-11-22 14:22
Proxy Solicitation & Information Statement
wzór pełnomocnictwa
Polish 2.4 MB
2024-11-22 14:22
Post-Annual General Meeting Information
projekty uchwał
Polish 1.2 MB
2024-11-22 14:22
Pre-Annual General Meeting Information
treść ogłoszenia o zwołaniu NWZ
Polish 806.7 KB
2024-11-22 14:22
Pre-Annual General Meeting Information
Zwołanie Nadzwyczajnego Walnego Zgromadzenia Spółki na 19 grudnia 2024 roku - C…
Polish 793 bytes
2024-11-21 12:51
Major Shareholding Notification
zawiadomienie BL
Polish 48.9 KB

Automate Your Workflow. Get a real-time feed of all Stem Cells Spin Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Stem Cells Spin Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Theranexus Logo
Biopharma developing drug candidates for rare neurological diseases like Batten disease.
France ALTHX
TME Pharma N.V. Logo
Clinical-stage biotech developing TME-targeting therapies for aggressive cancers.
Germany ALTME
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
Transgene Logo
Clinical-stage biotech using viral vectors for cancer vaccines and oncolytic viruses.
France TNG
Tvardi Therapeutics Inc. Logo United States of America TVRD
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
Hong Kong N/A
Urteste S.A. Logo
Developing non-invasive urine tests for early detection & monitoring of multiple cancers.
Poland URT
VALIRX PLC Logo
Developing early-stage therapeutics & diagnostics for oncology and women's health.
United Kingdom VAL